EUVIMEDEUVIMED entdecken
Crossref

Optimization of Chelator Conjugation to PD-1/VEGF Bispecific Antibody for 89 Zr-ImmunoPET Imaging

Yang Jiang, Xingguo Hou, Siqi Hao, Qian Chen, Qian Zhang, Yan Zhang, Zhi Yang iD, Hua Zhu iD

Journal of Medicinal Chemistry · 14.05.2026 · 69 (9) · 11397-11409

DOI: 10.1021/acs.jmedchem.6c00574 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 24.04.2026. Verfasst von Yang Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: GuiZhou University Medical College, Guiyang 550025, Guizhou Province, China. Hauptthemen laut MEDLINE: Zirconium, Antibodies, Bispecific, Radioisotopes, Chelating Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Scientific Research Foundation of Peking University Cancer Hospital, Youth Beijing Scholar 2024.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ZirconiumAntibodies, BispecificRadioisotopesChelating AgentsVascular Endothelial Growth Factor AProgrammed Cell Death 1 ReceptorRadiopharmaceuticalsAnimalsHumansMicePositron-Emission TomographyPositron Emission Tomography Computed TomographyTissue Distribution

Substanzen

ZirconiumAntibodies, BispecificRadioisotopesZirconium-89Chelating AgentsVascular Endothelial Growth Factor AProgrammed Cell Death 1 ReceptorPDCD1 protein, humanRadiopharmaceuticals

Autor:innen und Institutionen

  • GuiZhou University Medical College, Guiyang 550025, Guizhou Province, China.
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department…
  • Institute of Biomedical Engineering, Peking University Shenzhen Graduate School, Shenzhen, Guangdong 518055, China.

ORCID-Profile: Zhi Yang, Hua Zhu

Förderung

  • Scientific Research Foundation of Peking University Cancer Hospital
  • Youth Beijing Scholar 2024

Zitieren

APA

Jiang, Y., Hou, X., Hao, S., Chen, Q., Zhang, Q., Zhang, Y., Yang, Z., & Zhu, H. (2026). Optimization of Chelator Conjugation to PD-1/VEGF Bispecific Antibody for 89 Zr-ImmunoPET Imaging. Journal of Medicinal Chemistry, 69(9), 11397-11409. https://doi.org/10.1021/acs.jmedchem.6c00574

Vancouver

Jiang Y, Hou X, Hao S, Chen Q, Zhang Q, Zhang Y, et al. Optimization of Chelator Conjugation to PD-1/VEGF Bispecific Antibody for 89 Zr-ImmunoPET Imaging. Journal of Medicinal Chemistry. 2026;69(9):11397-11409. doi:10.1021/acs.jmedchem.6c00574

BibTeX
@article{Jiang2026,
  author = {Jiang, Yang and Hou, Xingguo and Hao, Siqi and Chen, Qian and Zhang, Qian and Zhang, Yan and Yang, Zhi and Zhu, Hua},
  title = {Optimization of Chelator Conjugation to PD-1/VEGF Bispecific Antibody for 89 Zr-ImmunoPET Imaging},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {9},
  pages = {11397--11409},
  doi = {10.1021/acs.jmedchem.6c00574}
}
Kostenlos starten →